Providing expert advice and strategic guidance to companies and VC organizations operating in the fields of
biology, pharmaceuticals, biotechnology, healthcare, and related sectors.
Founder and President
• Solutions for product development/innovation, market entry, business development strategies, and
optimizing commercial processes.

Phenomenex develops and manufacture separa@on technologies (HPLC/UHPLC) and sample prep technologies. (www.phenomenex.com) Director, Strategic Biopharma Business Development U@lized DBS tools (Kaizen, Standard Work, Growth Rooms, PSP, etc)
• Drove double digit expansion of PHX biopharma porholio into genomic medicines and workflows for biotherapeu@cs analy@cs.
• Lead alignment of PHX R&D, Applica@ons groups, Marke@ng, and Opera@ons to define and test new biopharma products and applica@ons driving new revenue.
• Worked closely with scien@sts, key opinion leaders, thought leaders worldwide, other Danaher companies to map out product/technology roadmap of new biopharma applica@ons/products.

Waters develops and manufactures liquid chromatography and mass spectrometer technologies (www.waters.com) Director, Life Sciences R&D and Business Development Worldwide Strategic business development of Waters Biopharmaceu@cal Business Opera@ons.
• Lead the expansion of WAT biopharma LC/MS into bioprocess analy@cs with Sartorius resul@ng in new revenue stream.
• Directed Waters Life Sciences R&D ac@vi@es between (12 PhD's and 2 MS scien@sts)
• Built Waters R&D program and technology plahorm for biopharmaceu@cal characteriza@on.
• Commercialized Waters first market specific LC/MS system solu@on the BioAccord LC/MS system for biopharma.
• Commercialized 2 major system solu@ons LC/MS plahorms (proteomics and biopharmaceu@cal characteriza@on)
• Managed the evalua@on and applica@on development on new LC systems, MS systems, LC/MS system solu@ons, and sokware tools.
• Communicated Waters R&D and applica@on achievements in peer reviewed journal ar@cles and 100s posters & orals in na@

One year assignment in India to develop Waters India MS business.
• Lead WAT to become the principal vendor for LC/MS in India biopharma market.
• Trained the Indian field sales and marke@ng personal on LC/MS for biopharma.
• Delivered scien@fic lectures through-out India on LC/MS technologies for life sciences.
• Evaluated the India MS market by extensive travel mee@ng scien@fic leaders in industry and academics to understand and evaluate the MS market.
• Created and executed strategies and tac@cs that grew Waters MS business in India with superior marke@ng.

Manager of Waters Life Sciences Chemistry group
• Built a R&D/applica@on lab for a WAT life sciences ini@a@ve in proteomics and biopharma resul@ng in millions of new revenues.
• Commercialized LC and MS consumables for sample prepara@on and system tes@ng with focus on proteomics.
• Developed/commercialized/patented unique mass spectrometer hardware.
• Created technical marke@ng collateral; peer-reviewed journal ar@cles, applica@on notes, videos, scien@fic mee@ng posters and orals.
• Developed a new market for Waters; the characteriza@on of oligonucleo@de by LC/UV and LC/MS (significant revenue 10s M/year)

ADD develops and manufactures automated clinical immunoassay systems (www.abbop.com) Principal ScienKst Established and managed ADD chemistry department mass spectrometry facility running 1000's samples/year.
• Directly involved in solving major manufacturing issues (FDA recalled) with several on-market ADD products.
• Developed advanced mass spectrometry characteriza@on techniques for proteins, an@bodies, protein conjugates, and an@body conjugates.
• Implemented semi-automa@c MS methods for organic synthesis group.
• Developed and implemented modern liquid chromatography (HPLC) and mass spectrometry methods for the characteriza@on of biologicals produced for immunoassays (an@bodies, protein, bioconjugates, small molecules and pep@des)
• Developed chemoenzyma@c methods the synthesis of labile compounds.
• Func@oned as a Team member of Abbop/Wyeth R&D efort for new immunoassay products.
• Established new HPLC bioanaly@cal techniques and methods for the department.
• Published pe